Charles Schwab’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$109M Sell
1,137,006
-14,854
-1% -$1.43M 0.01% 745
2026
Q1
$119M Buy
1,151,860
+43,191
+4% +$4.9M 0.02% 637
2025
Q4
$112M Buy
1,108,669
+21,211
+2% +$2.3M 0.02% 674
2025
Q3
$134M Buy
1,087,458
+332,934
+44% +$41.3M 0.02% 563
2025
Q2
$90.6M Buy
754,524
+1,538
+0.2% +$205K 0.02% 725
2025
Q1
$111M Buy
752,986
+4,866
+0.7% +$743K 0.02% 606
2024
Q4
$122M Buy
748,120
+24,214
+3% +$3.96M 0.02% 561
2024
Q3
$118M Buy
723,906
+13,038
+2% +$1.93M 0.02% 573
2024
Q2
$97M Buy
710,868
+15,645
+2% +$2.17M 0.02% 662
2024
Q1
$106M Buy
695,223
+16,398
+2% +$2.45M 0.02% 576
2023
Q4
$96.8M Buy
678,825
+15,187
+2% +$2.02M 0.02% 572
2023
Q3
$87M Buy
663,638
+3,696
+0.6% +$562K 0.02% 564
2023
Q2
$105M Sell
659,942
-3,534
-0.5% -$570K 0.03% 497
2023
Q1
$105M Buy
663,476
+2,340
+0.4% +$351K 0.03% 473
2022
Q4
$92.8M Buy
661,136
+18,021
+3% +$2.56M 0.03% 506
2022
Q3
$82.6M Buy
643,115
+21,193
+3% +$3.06M 0.03% 507
2022
Q2
$87.7M Buy
621,922
+6,505
+1% +$929K 0.03% 503
2022
Q1
$85.6M Buy
615,417
+25,278
+4% +$3.87M 0.03% 582
2021
Q4
$103M Buy
590,139
+21,306
+4% +$3.55M 0.03% 519
2021
Q3
$94.2M Buy
568,833
+5,416
+1% +$933K 0.03% 519
2021
Q2
$101M Buy
563,417
+11,205
+2% +$2.05M 0.03% 487
2021
Q1
$107M Buy
552,212
+10,814
+2% +$2.08M 0.04% 418
2020
Q4
$109M Buy
541,398
+3,395
+0.6% +$703K 0.04% 385
2020
Q3
$113M Sell
538,003
-20,009
-4% -$4.46M 0.05% 329
2020
Q2
$122M Sell
558,012
-501,266
-47% -$100M 0.06% 293
2020
Q1
$184M Buy
1,059,278
+60,181
+6% +$9.94M 0.11% 182
2019
Q4
$153M Buy
999,097
+18,142
+2% +$2.71M 0.08% 223
2019
Q3
$149M Buy
980,955
+11,112
+1% +$1.76M 0.09% 212
2019
Q2
$148M Buy
969,843
+39,390
+4% +$6.02M 0.09% 211
2019
Q1
$149M Buy
930,453
+40,043
+4% +$6.21M 0.1% 193
2018
Q4
$137M Buy
890,410
+36,518
+4% +$5.69M 0.11% 180
2018
Q3
$128M Buy
853,892
+19,941
+2% +$2.83M 0.09% 212
2018
Q2
$113M Buy
833,951
+29,747
+4% +$3.67M 0.08% 227
2018
Q1
$107M Buy
804,204
+126,312
+19% +$17M 0.08% 231
2017
Q4
$101M Buy
677,892
+39,624
+6% +$5.39M 0.08% 237
2017
Q3
$84.2M Buy
638,268
+21,570
+3% +$2.9M 0.07% 260
2017
Q2
$82.2M Buy
616,698
+29,968
+5% +$4.04M 0.08% 255
2017
Q1
$79.1M Buy
586,730
+23,243
+4% +$3.01M 0.08% 249
2016
Q4
$67.6M Buy
563,487
+22,332
+4% +$2.63M 0.07% 262
2016
Q3
$67.7M Buy
541,155
+42,506
+9% +$5.57M 0.08% 252
2016
Q2
$69M Sell
498,649
-30,931
-6% -$4.01M 0.09% 238
2016
Q1
$66.8M Buy
529,580
+6,995
+1% +$889K 0.09% 233
2015
Q4
$66.3M Buy
522,585
+82,834
+19% +$10.3M 0.09% 216
2015
Q3
$50.8M Buy
439,751
+24,896
+6% +$2.79M 0.07% 260
2015
Q2
$43.2M Sell
414,855
-894
-0.2% -$96.5K 0.06% 319
2015
Q1
$45.9M Buy
415,749
+29,332
+8% +$3.18M 0.06% 297
2014
Q4
$40.3M Buy
386,417
+28,611
+8% +$2.86M 0.06% 304
2014
Q3
$34.4M Buy
357,806
+15,665
+5% +$1.42M 0.06% 319
2014
Q2
$31.3M Buy
342,141
+17,481
+5% +$1.57M 0.05% 349
2014
Q1
$28.6M Buy
324,660
+70,835
+28% +$6.22M 0.05% 359
2013
Q4
$23.5M Sell
253,825
-10,102
-4% -$910K 0.04% 388
2013
Q3
$21.7M Buy
263,927
+15,081
+6% +$1.27M 0.04% 386
2013
Q2
$20.9M Buy
+248,846
New +$21.4M 0.05% 366

Other funds holding CLX

Charles Schwab's CLX Position: Q2 2026 in Review

Charles Schwab reduced its Clorox (CLX) stake by 1.3% in Q2 2026, selling an estimated $1.43M and leaving 1,137,006 shares worth $109M. The position accounts for 0.01% of the portfolio, ranked #745.

Charles Schwab first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $184M in Q1 2020. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Charles Schwab held 1,137,006 shares of Clorox worth $109M as of Q2 2026.
  • Charles Schwab sold 14,854 Clorox shares in Q2 2026, an estimated $1.43M.
  • Clorox made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #745 holding.
  • Charles Schwab first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
  • Charles Schwab's Clorox position peaked at $184M in Q1 2020.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.